Stenóza karotidy
| Název práce v češtině: | Stenóza karotidy |
|---|---|
| Název v anglickém jazyce: | Carotid Artery Stenosis |
| Klíčová slova: | Stenóza karotidy, karotický plát, biomarkery, digitální subtrakční angiografie, histologie |
| Klíčová slova anglicky: | Carotid Stenosis, Carotid Artery Plauqe, Biomarkers, Digital Subtraction Angiography, Histology |
| Akademický rok vypsání: | 2016/2017 |
| Typ práce: | disertační práce |
| Jazyk práce: | čeština |
| Ústav: | Neurochirurgická a neuroonkologická klinika 1. LF UK a ÚVN (11-00860) |
| Vedoucí / školitel: | prof. MUDr. Vladimír Beneš, DrSc. |
| Řešitel: | skrytý - zadáno a potvrzeno stud. odd. |
| Datum přihlášení: | 12.10.2016 |
| Datum zadání: | 12.10.2016 |
| Datum potvrzení stud. oddělením: | 12.10.2016 |
| Datum a čas obhajoby: | 11.09.2023 14:30 |
| Místo konání obhajoby: | Kateřinská 30, Praha 2, budova D5, NEURP1, Kateřinská 30, přízemí, posluchárna |
| Datum odevzdání elektronické podoby: | 27.05.2023 |
| Datum proběhlé obhajoby: | 11.09.2023 |
| Předmět: | Obhajoba dizertační práce (B90002) |
| Oponenti: | MUDr. Tomáš Peisker, Ph.D. |
| prof. MUDr. Roman Herzig, Ph.D. | |
| Seznam odborné literatury |
| 1 Boehme, A. K., Esenwa, C. & Elkind, M. S. Stroke Risk Factors, Genetics, and Prevention. Circ Res120, 472-495, doi:10.1161/CIRCRESAHA.116.308398 (2017).
2 Sarikaya, H., Ferro, J. & Arnold, M. Stroke prevention--medical and lifestyle measures. Eur Neurol73, 150-157, doi:10.1159/000367652 (2015). 3 Kastrup, A., Schnaudigel, S., Wasser, K. & Groschel, K. Carotid artery disease: stenting versus endarterectomy. Curr Atheroscler Rep10, 391-397, doi:10.1007/s11883-008-0061-8 (2008). 4 Paraskevas, K. I. et al. Asymptomatic carotid stenosis and cognitive impairment. J Cardiovasc Surg (Torino), doi:10.23736/S0021-9509.23.12620-6 (2023). 5 Robicsek, F., Roush, T. S., Cook, J. W. & Reames, M. K. From Hippocrates to Palmaz-Schatz, the history of carotid surgery. Eur J Vasc Endovasc Surg27, 389-397, doi:10.1016/j.ejvs.2004.01.004 (2004). 6 Stevanovic, K. et al. A Brief History of Carotid Artery Surgery and Anesthesia. J Anesth Hist2, 147-150, doi:10.1016/j.janh.2016.09.005 (2016). 7 Munster, A. B., Thapar, A. & Davies, A. H. History of Carotid Stroke. Stroke47, e66-69, doi:10.1161/STROKEAHA.115.012044 (2016). 8 Tindall, G. T., Goree, J. A., Lee, J. F. & Odom, G. L. Effect of common carotid ligation on size of internal carotid aneurysms and distal intracarotid and retinal artery pressures. J Neurosurg25, 503-511, doi:10.3171/jns.1966.25.5.0503 (1966). 9 Mayerl, C. et al. Atherosclerosis research from past to present--on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow. Virchows Arch449, 96-103, doi:10.1007/s00428-006-0176-7 (2006). 10 Drake, C. G. Earlier times in aneurysm surgery. Clin Neurosurg32, 41-50 (1985). 11 Flaherty, M. L. et al. Carotid artery stenosis as a cause of stroke. Neuroepidemiology40, 36-41, doi:10.1159/000341410 (2013). 12 Tyrrell, D. J. & Goldstein, D. R. Ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of IL-6. Nat Rev Cardiol18, 58-68, doi:10.1038/s41569-020-0431-7 (2021). 13 Giri, A. et al. Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet51, 51-62, doi:10.1038/s41588-018-0303-9 (2019). 14 Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet50, 1505-1513, doi:10.1038/s41588-018-0241-6 (2018). 15 Forstermann, U., Xia, N. & Li, H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis. Circ Res120, 713-735, doi:10.1161/CIRCRESAHA.116.309326 (2017). 16 Bhatnagar, A. Environmental Determinants of Cardiovascular Disease. Circ Res121, 162-180, doi:10.1161/CIRCRESAHA.117.306458 (2017). 17 Kim, J. S., Kang, D. W. & Kwon, S. U. Intracranial atherosclerosis: incidence, diagnosis and treatment. J Clin Neurol1, 1-7, doi:10.3988/jcn.2005.1.1.1 (2005). 18 Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation137, e67-e492, doi:10.1161/CIR.0000000000000558 (2018). 19 Schloss, M. J., Swirski, F. K. & Nahrendorf, M. Modifiable Cardiovascular Risk, Hematopoiesis, and Innate Immunity. Circ Res126, 1242-1259, doi:10.1161/CIRCRESAHA.120.315936 (2020). 20 Dominguez, F. et al. Association of Sleep Duration and Quality With Subclinical Atherosclerosis. J Am Coll Cardiol73, 134-144, doi:10.1016/j.jacc.2018.10.060 (2019). 21 Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun8, 845, doi:10.1038/s41467-017-00900-1 (2017). 22 Biddinger, K. J. et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open5, e223849, doi:10.1001/jamanetworkopen.2022.3849 (2022). 23 Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat Med28, 583-590, doi:10.1038/s41591-022-01689-3 (2022). 24 Krejza, J. et al. Carotid artery diameter in men and women and the relation to body and neck size. Stroke37, 1103-1105, doi:10.1161/01.STR.0000206440.48756.f7 (2006). 25 Geibprasert, S., Pongpech, S., Armstrong, D. & Krings, T. Dangerous extracranial-intracranial anastomoses and supply to the cranial nerves: vessels the neurointerventionalist needs to know. AJNR Am J Neuroradiol30, 1459-1468, doi:10.3174/ajnr.A1500 (2009). 26 Bjorkegren, J. L. M. & Lusis, A. J. Atherosclerosis: Recent developments. Cell185, 1630-1645, doi:10.1016/j.cell.2022.04.004 (2022). 27 Boren, J. & Williams, K. J. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol27, 473-483, doi:10.1097/MOL.0000000000000330 (2016). 28 Kattoor, A. J., Pothineni, N. V. K., Palagiri, D. & Mehta, J. L. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep19, 42, doi:10.1007/s11883-017-0678-6 (2017). 29 Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med19, 1166-1172, doi:10.1038/nm.3258 (2013). 30 Alencar, G. F. et al. Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis. Circulation142, 2045-2059, doi:10.1161/CIRCULATIONAHA.120.046672 (2020). 31 Bick, A. G. et al. Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV. Sci Rep12, 577, doi:10.1038/s41598-021-04308-2 (2022). 32 Grootaert, M. O. J., Finigan, A., Figg, N. L., Uryga, A. K. & Bennett, M. R. SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis. Circ Res128, 474-491, doi:10.1161/CIRCRESAHA.120.318353 (2021). 33 Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature599, 628-634, doi:10.1038/s41586-021-04103-z (2021). 34 Koyama, S. et al. Population-specific and trans-ancestry genome-wide analyses identify distinct and shared genetic risk loci for coronary artery disease. Nat Genet52, 1169-1177, doi:10.1038/s41588-020-0705-3 (2020). 35 Graham, S. E. et al. The power of genetic diversity in genome-wide association studies of lipids. Nature600, 675-679, doi:10.1038/s41586-021-04064-3 (2021). 36 Brinjikji, W. et al. Ultrasound Characteristics of Symptomatic Carotid Plaques: A Systematic Review and Meta-Analysis. Cerebrovasc Dis40, 165-174, doi:10.1159/000437339 (2015). 37 Shao, S. et al. Differences in left and right carotid plaque vulnerability in patients with bilateral carotid plaques: a CARE-II study. Stroke Vasc Neurol, doi:10.1136/svn-2022-001937 (2023). 38 Wendorff, C. et al. Carotid Plaque Morphology Is Significantly Associated With Sex, Age, and History of Neurological Symptoms. Stroke46, 3213-3219, doi:10.1161/STROKEAHA.115.010558 (2015). 39 Hetterich, H. et al. AHA classification of coronary and carotid atherosclerotic plaques by grating-based phase-contrast computed tomography. Eur Radiol26, 3223-3233, doi:10.1007/s00330-015-4143-z (2016). 40 McColgan, P., Bentley, P., McCarron, M. & Sharma, P. Evaluation of the clinical utility of a carotid bruit. QJM105, 1171-1177, doi:10.1093/qjmed/hcs140 (2012). 41 Moniz, E. [Subsidies for the history of angiography]. Med Contemp73, 329-346 (1955). 42 Ferguson, G. G. et al. The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke30, 1751-1758, doi:10.1161/01.str.30.9.1751 (1999). 43 Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet351, 1379-1387 (1998). 44 Svoboda, N., Bradac, O., Mandys, V., Netuka, D. & Benes, V. Diagnostic accuracy of DSA in carotid artery stenosis: a comparison between stenosis measured on carotid endarterectomy specimens and DSA in 644 cases. Acta Neurochir (Wien)164, 3197-3202, doi:10.1007/s00701-022-05332-5 (2022). 45 Mnyusiwalla, A., Aviv, R. I. & Symons, S. P. Radiation dose from multidetector row CT imaging for acute stroke. Neuroradiology51, 635-640, doi:10.1007/s00234-009-0543-6 (2009). 46 McNally, J. S. et al. Magnetic Resonance Imaging Detection of Intraplaque Hemorrhage. Magn Reson Insights10, 1-8, doi:10.1177/1178623X17694150 (2017). 47 Sander, K., Horn, C. S., Briesenick, C., Sander, D. & Group, I. S. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study. Stroke38, 2881-2886, doi:10.1161/STROKEAHA.106.481531 (2007). 48 Debing, E., Peeters, E., Demanet, C., De Waele, M. & Van den Brande, P. Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc Endovascular Surg42, 122-127, doi:10.1177/1538574407307406 (2008). 49 Talayero, B. G. & Sacks, F. M. The role of triglycerides in atherosclerosis. Curr Cardiol Rep13, 544-552, doi:10.1007/s11886-011-0220-3 (2011). 50 Yeh, P. S. et al. Low levels of high-density lipoprotein cholesterol in patients with atherosclerotic stroke: a prospective cohort study. Atherosclerosis228, 472-477, doi:10.1016/j.atherosclerosis.2013.03.015 (2013). 51 Walsh, K. B. et al. Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis. J Stroke Cerebrovasc Dis25, 1360-1365, doi:10.1016/j.jstrokecerebrovasdis.2016.02.027 (2016). 52 Kigka, V. I. et al. Serum Biomarkers in Carotid Artery Disease. Diagnostics (Basel)11, doi:10.3390/diagnostics11112143 (2021). 53 Kang, S., Wu, Y. & Li, X. Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis177, 433-442, doi:10.1016/j.atherosclerosis.2004.08.005 (2004). 54 Whayne, T. F., Jr. Assessment of Carotid Artery Stenosis and the Use of Statins. Int J Angiol24, 173-178, doi:10.1055/s-0035-1554910 (2015). 55 Amarenco, P. et al. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke45, 2974-2982, doi:10.1161/STROKEAHA.114.005832 (2014). 56 Brott, T. G. et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Circulation124, e54-130, doi:10.1161/CIR.0b013e31820d8c98 (2011). 57 Ogata, A. et al. Stabilization of vulnerable carotid plaques with proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab. Acta Neurochir (Wien)161, 597-600, doi:10.1007/s00701-019-03825-4 (2019). 58 Kernan, W. N. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke45, 2160-2236, doi:10.1161/STR.0000000000000024 (2014). 59 Shon, S. M. et al. Cytokine Response to Diet and Exercise Affects Atheromatous Matrix Metalloproteinase-2/9 Activity in Mice. Circ J81, 1528-1536, doi:10.1253/circj.CJ-16-1196 (2017). 60 Weiss, E. P. et al. Effects of matched weight loss from calorie restriction, exercise, or both on cardiovascular disease risk factors: a randomized intervention trial. Am J Clin Nutr104, 576-586, doi:10.3945/ajcn.116.131391 (2016). 61 Coffeng, J. K. et al. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial. Am Heart J184, 121-132, doi:10.1016/j.ahj.2016.11.002 (2017). 62 Halliday, A. et al. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy. Lancet398, 1065-1073, doi:10.1016/S0140-6736(21)01910-3 (2021). 63 Jusufovic, M., Sandset, E. C., Skagen, K. & Skjelland, M. Blood Pressure Lowering Treatment in Patients with Carotid Artery Stenosis. Curr Hypertens Rev12, 148-155, doi:10.2174/157340211202160525010133 (2016). 64 Yokoyama, H., Katakami, N. & Yamasaki, Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke37, 2420-2427, doi:10.1161/01.STR.0000236632.58323.cd (2006). 65 Cote, R. et al. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. The Asymptomatic Cervical Bruit Study Group. Ann Intern Med123, 649-655, doi:10.7326/0003-4819-123-9-199511010-00002 (1995). 66 Meschia, J. F. et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke45, 3754-3832, doi:10.1161/STR.0000000000000046 (2014). 67 Bhatia, K. et al. Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials. Stroke52, e217-e223, doi:10.1161/STROKEAHA.120.033033 (2021). 68 Naylor, A. R. et al. Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. Eur J Vasc Endovasc Surg46, 161-170, doi:10.1016/j.ejvs.2013.05.005 (2013). 69 Bonati, L. H. et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J6, I, doi:10.1177/23969873211026990 (2021). 70 AbuRahma, A. F., Stone, P. A., Flaherty, S. K. & AbuRahma, Z. Prospective randomized trial of ACUSEAL (Gore-Tex) versus Hemashield-Finesse patching during carotid endarterectomy: early results. J Vasc Surg45, 881-884, doi:10.1016/j.jvs.2007.01.038 (2007). 71 Doig, D. et al. Predictors of Stroke, Myocardial Infarction or Death within 30 Days of Carotid Artery Stenting: Results from the International Carotid Stenting Study. Eur J Vasc Endovasc Surg51, 327-334, doi:10.1016/j.ejvs.2015.08.013 (2016). 72 Hye, R. J. et al. Incidence, outcomes, and effect on quality of life of cranial nerve injury in the Carotid Revascularization Endarterectomy versus Stenting Trial. J Vasc Surg61, 1208-1214, doi:10.1016/j.jvs.2014.12.039 (2015). 73 Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA273, 1421-1428 (1995). 74 Halliday, A. et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet363, 1491-1502, doi:10.1016/S0140-6736(04)16146-1 (2004). 75 Bekelis, K., Moses, Z., Missios, S., Desai, A. & Labropoulos, N. Indications for treatment of recurrent carotid stenosis. Br J Surg100, 440-447, doi:10.1002/bjs.9027 (2013). 76 Garzon-Muvdi, T. et al. Restenosis After Carotid Endarterectomy: Insight Into Risk Factors and Modification of Postoperative Management. World Neurosurg89, 159-167, doi:10.1016/j.wneu.2016.01.028 (2016). 77 O'Hara, P. J. et al. Reoperation for recurrent carotid stenosis: early results and late outcome in 199 patients. J Vasc Surg34, 5-12, doi:10.1067/mva.2001.115601 (2001). 78 Ederle, J. et al. Effect of white-matter lesions on the risk of periprocedural stroke after carotid artery stenting versus endarterectomy in the International Carotid Stenting Study (ICSS): a prespecified analysis of data from a randomised trial. Lancet Neurol12, 866-872, doi:10.1016/S1474-4422(13)70135-2 (2013). 79 Brott, T. G. et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med363, 11-23, doi:10.1056/NEJMoa0912321 (2010). 80 Moulakakis, K. G. et al. Acute Carotid Stent Thrombosis: A Comprehensive Review. Vasc Endovascular Surg50, 511-521, doi:10.1177/1538574416665986 (2016). 81 Schonholz, C. J., Uflacker, R., Parodi, J. C., Hannegan, C. & Selby, B. Is there evidence that cerebral protection is beneficial? Clinical data. J Cardiovasc Surg (Torino)47, 137-141 (2006). 82 Barbato, J. E. et al. A randomized trial of carotid artery stenting with and without cerebral protection. J Vasc Surg47, 760-765, doi:10.1016/j.jvs.2007.11.058 (2008). 83 Brott, T. G. et al. Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med374, 1021-1031, doi:10.1056/NEJMoa1505215 (2016). 84 Lal, B. K. et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol11, 755-763, doi:10.1016/S1474-4422(12)70159-X (2012). 85 Bonati, L. H. et al. Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial. Lancet Neurol17, 587-596, doi:10.1016/S1474-4422(18)30195-9 (2018). 86 Bonati, L. H. et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial. Lancet385, 529-538, doi:10.1016/S0140-6736(14)61184-3 (2015). 87 AbuRahma, A. F. et al. The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease. J Vasc Surg75, 26S-98S, doi:10.1016/j.jvs.2021.04.074 (2022). 88 Aboyans, V. et al. [2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]. Kardiol Pol75, 1065-1160, doi:10.5603/KP.2017.0216 (2017). 89 Verhoeven, B. et al. Carotid atherosclerotic plaques in patients with transient ischemic attacks and stroke have unstable characteristics compared with plaques in asymptomatic and amaurosis fugax patients. J Vasc Surg42, 1075-1081, doi:10.1016/j.jvs.2005.08.009 (2005). 90 Stary, H. C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation92, 1355-1374, doi:10.1161/01.cir.92.5.1355 (1995). 91 Bechynska, K. et al. The effect of omega-3 polyunsaturated fatty acids on the liver lipidome, proteome and bile acid profile: parenteral versus enteral administration. Sci Rep9, 19097, doi:10.1038/s41598-019-54225-8 (2019). 92 Ohara, T. et al. Eccentric stenosis of the carotid artery associated with ipsilateral cerebrovascular events. AJNR Am J Neuroradiol29, 1200-1203, doi:10.3174/ajnr.A0997 (2008). 93 Saba, L. et al. Imaging of the carotid artery vulnerable plaque. Cardiovasc Intervent Radiol37, 572-585, doi:10.1007/s00270-013-0711-2 (2014). 94 Waxman, S. et al. Plaque disruption and thrombus in Ambrose's angiographic coronary lesion types. Am J Cardiol92, 16-20, doi:10.1016/s0002-9149(03)00457-0 (2003). 95 Yamagishi, M. et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol35, 106-111, doi:10.1016/s0735-1097(99)00533-1 (2000). 96 Ambrose, J. A. et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol5, 609-616, doi:10.1016/s0735-1097(85)80384-3 (1985). 97 Ambrose, J. A. et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol6, 1233-1238, doi:10.1016/s0735-1097(85)80207-2 (1985). 98 Carr, S., Farb, A., Pearce, W. H., Virmani, R. & Yao, J. S. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg23, 755-765; discussion 765-756, doi:10.1016/s0741-5214(96)70237-9 (1996). 99 van Oostrom, O. et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol14, 126-134, doi:10.1016/j.carpath.2005.03.002 (2005). 100 Kwee, R. M. Systematic review on the association between calcification in carotid plaques and clinical ischemic symptoms. J Vasc Surg51, 1015-1025, doi:10.1016/j.jvs.2009.08.072 (2010). 101 Shaalan, W. E. et al. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg40, 262-269, doi:10.1016/j.jvs.2004.04.025 (2004). 102 Howard, D. P. et al. Symptomatic carotid atherosclerotic disease: correlations between plaque composition and ipsilateral stroke risk. Stroke46, 182-189, doi:10.1161/STROKEAHA.114.007221 (2015). 103 Selwaness, M. et al. Carotid Atherosclerotic Plaque Characteristics on Magnetic Resonance Imaging Relate With History of Stroke and Coronary Heart Disease. Stroke47, 1542-1547, doi:10.1161/STROKEAHA.116.012923 (2016). 104 Fisher, M. et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke36, 253-257, doi:10.1161/01.STR.0000152336.71224.21 (2005). 105 Takaya, N. et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI--initial results. Stroke37, 818-823, doi:10.1161/01.STR.0000204638.91099.91 (2006). 106 Parmar, J. P. et al. Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke. Circulation122, 2031-2038, doi:10.1161/CIRCULATIONAHA.109.866053 (2010). 107 Turc, G. et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol32, 492-499, doi:10.1161/ATVBAHA.111.239335 (2012). 108 Golledge, J., Greenhalgh, R. M. & Davies, A. H. The symptomatic carotid plaque. Stroke31, 774-781, doi:10.1161/01.str.31.3.774 (2000). 109 Peeters, W. et al. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization. Arterioscler Thromb Vasc Biol29, 128-133, doi:10.1161/ATVBAHA.108.173658 (2009). 110 Salem, M. K. et al. Features of unstable carotid plaque during and after the hyperacute period following TIA/stroke. Eur J Vasc Endovasc Surg45, 114-120, doi:10.1016/j.ejvs.2012.11.023 (2013). 111 Kockx, M. M. et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation97, 2307-2315, doi:10.1161/01.cir.97.23.2307 (1998). 112 Redgrave, J. N., Lovett, J. K. & Rothwell, P. M. Histological features of symptomatic carotid plaques in relation to age and smoking: the oxford plaque study. Stroke41, 2288-2294, doi:10.1161/STROKEAHA.110.587006 (2010). 113 Waden, K. et al. Clinical risk scores for stroke correlate with molecular signatures of vulnerability in symptomatic carotid patients. iScience25, 104219, doi:10.1016/j.isci.2022.104219 (2022). 114 Stary, H. C. Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries. Basic Res Cardiol89 Suppl 1, 17-32, doi:10.1007/978-3-642-85660-0_2 (1994). 115 Stary, H. C. Natural history and histological classification of atherosclerotic lesions: an update. Arterioscler Thromb Vasc Biol20, 1177-1178, doi:10.1161/01.atv.20.5.1177 (2000). 116 Netuka, D. et al. Detection of carotid artery stenosis using histological specimens: a comparison of CT angiography, magnetic resonance angiography, digital subtraction angiography and Doppler ultrasonography. Acta Neurochir (Wien)158, 1505-1514, doi:10.1007/s00701-016-2842-0 (2016). 117 Alexandrov, A. V., Bladin, C. F., Maggisano, R. & Norris, J. W. Measuring carotid stenosis. Time for a reappraisal. Stroke24, 1292-1296, doi:10.1161/01.str.24.9.1292 (1993). 118 Schenk, E. A. et al. Multicenter validation study of real-time ultrasonography, arteriography, and pathology: pathologic evaluation of carotid endarterectomy specimens. Stroke19, 289-296, doi:10.1161/01.str.19.3.289 (1988). 119 Kashyap, V. S. et al. Angiography underestimates peripheral atherosclerosis: lumenography revisited. J Endovasc Ther15, 117-125, doi:10.1583/07-2249R.1 (2008). 120 Isner, J. M. et al. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic--histologic correlative analysis in 28 patients. Circulation63, 1056-1064, doi:10.1161/01.cir.63.5.1056 (1981). 121 Svoboda, N. et al. Histological Analysis of Carotid Plaques: The Predictors of Stroke Risk. J Stroke Cerebrovasc Dis31, 106262, doi:10.1016/j.jstrokecerebrovasdis.2021.106262 (2022). 122 Stary, H. C. Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol421, 277-290, doi:10.1007/BF01660974 (1992). 123 Puig, N., Jimenez-Xarrie, E., Camps-Renom, P. & Benitez, S. Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability. Int J Mol Sci21, doi:10.3390/ijms21218236 (2020). 124 Sigala, F. et al. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. J Vasc Surg52, 704-713, doi:10.1016/j.jvs.2010.03.047 (2010). 125 Sies, H. Oxidative stress: a concept in redox biology and medicine. Redox Biol4, 180-183, doi:10.1016/j.redox.2015.01.002 (2015). 126 Xie, M. et al. BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress. Circ Res126, e15-e29, doi:10.1161/CIRCRESAHA.119.315502 (2020). 127 Wang, Y., Wang, G. Z., Rabinovitch, P. S. & Tabas, I. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kappaB-mediated inflammation in macrophages. Circ Res114, 421-433, doi:10.1161/CIRCRESAHA.114.302153 (2014). 128 Liu, P. & Pan, Q. Butein Inhibits Oxidative Stress Injury in Rats with Chronic Heart Failure via ERK/Nrf2 Signaling. Cardiovasc Ther2022, 8684014, doi:10.1155/2022/8684014 (2022). 129 Joseph, L. C. et al. Mitochondrial oxidative stress during cardiac lipid overload causes intracellular calcium leak and arrhythmia. Heart Rhythm13, 1699-1706, doi:10.1016/j.hrthm.2016.05.002 (2016). 130 Pietraforte, D. et al. Redox control of platelet functions in physiology and pathophysiology. Antioxid Redox Signal21, 177-193, doi:10.1089/ars.2013.5532 (2014). 131 Incalza, M. A. et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol100, 1-19, doi:10.1016/j.vph.2017.05.005 (2018). 132 Kim, K., Li, J., Tseng, A., Andrews, R. K. & Cho, J. NOX2 is critical for heterotypic neutrophil-platelet interactions during vascular inflammation. Blood126, 1952-1964, doi:10.1182/blood-2014-10-605261 (2015). 133 Marrocco, I., Altieri, F. & Peluso, I. Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans. Oxid Med Cell Longev2017, 6501046, doi:10.1155/2017/6501046 (2017). 134 Li, Z. et al. The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis. Oxid Med Cell Longev2022, 8418820, doi:10.1155/2022/8418820 (2022). 135 Cano, C. P. et al. Increased serum malondialdehyde and decreased nitric oxide within 24 hours of thrombotic stroke onset. Am J Ther10, 473-476, doi:10.1097/00045391-200311000-00018 (2003). 136 Re, G. et al. Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism. Eur J Emerg Med4, 5-9 (1997). 137 Hajsl, M. et al. Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease. Metabolites10, doi:10.3390/metabo10050208 (2020). 138 Kosek, V. et al. Long-Term Effects on the Lipidome of Acute Coronary Syndrome Patients. Metabolites12, doi:10.3390/metabo12020124 (2022). 139 Rasic, S., Rebic, D., Hasic, S., Rasic, I. & Delic Sarac, M. Influence of Malondialdehyde and Matrix Metalloproteinase-9 on Progression of Carotid Atherosclerosis in Chronic Renal Disease with Cardiometabolic Syndrome. Mediators Inflamm2015, 614357, doi:10.1155/2015/614357 (2015). 140 Lankin, V. Z., Tikhaze, A. K. & Melkumyants, A. M. Malondialdehyde as an Important Key Factor of Molecular Mechanisms of Vascular Wall Damage under Heart Diseases Development. Int J Mol Sci24, doi:10.3390/ijms24010128 (2022). 141 Suttnar, J., Otahalova, E., Cermak, J. & Dyr, J. E. Effects of malondialdehyde content in low density lipoproteins on platelet adhesion. Platelets17, 92-99, doi:10.1080/09537100500261590 (2006). 142 Johnston, J. W., Horne, S., Harding, K. & Benson, E. E. Evaluation of the 1-methyl-2-phenylindole colorimetric assay for aldehydic lipid peroxidation products in plants: malondialdehyde and 4-hydroxynonenal. Plant Physiol Biochem45, 108-112, doi:10.1016/j.plaphy.2007.01.011 (2007). 143 Ichikawa, K., Miyoshi, T., Osawa, K., Miki, T. & Ito, H. Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is Associated with High-Risk Plaque in Coronary Computed Tomography Angiography in Patients Receiving Statin Therapy. J Clin Med10, doi:10.3390/jcm10071480 (2021). 144 Aboyans, V. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Rev Esp Cardiol (Engl Ed)71, 111, doi:10.1016/j.rec.2017.12.014 (2018). |
| Předběžná náplň práce |
| disertační práce se skládá ze dvou částí:
1) retrospektivní část: Analýza výsledků DSA, CT angigrafie a duplexní sonografie a porovnání se skutečnou stenózou karotidy na odstraněném plátu. 2) prospektivní část: hodnocení vstupních vyšetření (fyzikální + anamnestické, DSA, CT angiografie, duplexní sonografie), porovnání vstupních údajů s odstraněným plátem, hodnocení výsledku operace v závislosti na stenóze a symptomatologii. |
| Předběžná náplň práce v anglickém jazyce |
| PhD thesis consists of two parts:
Retrospective part: Analysis of DSA (Digital Subtraction Angiography), CT angiography, and duplex sonography results, and comparison with actual carotid stenosis on the removed plaque. Prospective part: Evaluation of initial examinations (physical + anamnestic, DSA, CT angiography, duplex sonography), comparison of initial data with the removed plaque, assessment of surgical outcome based on stenosis and symptomatology. |